Vitamin C pharmacokinetics: implications for oral and intravenous use.
about
Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effectsAntiproliferative effect of ascorbic acid is associated with the inhibition of genes necessary to cell cycle progressionVitamin C for treating atrial fibrillationVitamin C for preventing and treating pneumoniaVitamin C for preventing and treating the common coldVitamin C for preventing and treating tetanusVitamin C for preventing and treating tetanusVitamin C for preventing and treating pneumoniaVitamin C for preventing and treating the common coldVitamin C for preventing and treating tetanusPharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues.Intravenously administered vitamin C as cancer therapy: three casesPharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in miceA 12 week, open label, phase I/IIa study using apatone for the treatment of prostate cancer patients who have failed standard therapyChanges of terminal cancer patients' health-related quality of life after high dose vitamin C administrationVitamin C: update on physiology and pharmacologyAscorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivoNutrition and cancer: a review of the evidence for an anti-cancer dietMisleading information on the properties of vitamin CNarrow scope of vitamin C reviewVitamin C for treating atrial fibrillationTreatment of Pancreatic Cancer with Pharmacological AscorbateAscorbate as a co-factor for fe- and 2-oxoglutarate dependent dioxygenases: physiological activity in tumor growth and progressionRegulation of vitamin C homeostasis during deficiencyRadiographic contrast-media-induced acute kidney injury: pathophysiology and prophylactic strategiesIncreasing Superoxide Production and the Labile Iron Pool in Tumor Cells may Sensitize Them to Extracellular AscorbateCan supplementation with vitamin C and E alter physiological adaptations to strength training?Ascorbic acid and a cytostatic inhibitor of glycolysis synergistically induce apoptosis in non-small cell lung cancer cellsIncreased ventilatory response to carbon dioxide in COPD patients following vitamin C administrationPostprandial Metabolism of Macronutrients and Cardiometabolic Risk: Recent Developments, Emerging Concepts, and Future Directions.Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancerIntravenous vitamin C in the treatment of post-laser hyperpigmentation for melasma: a short report.The role of vitamin C in the treatment of pain: new insights.Vitamin C transporter Slc23a1 links renal reabsorption, vitamin C tissue accumulation, and perinatal survival in mice.Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial.Intravenous vitamin C administration reduces fatigue in office workers: a double-blind randomized controlled trial.Effect of Vitamin C Supplementation on C-reactive Protein Levels in Patients Undergoing Hemodialysis: A Randomized, Double Blind, Placebo-Controlled Study.Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.Antioxidants and Other Micronutrients in Complementary Oncology.The effect of intravenous vitamin C on cancer- and chemotherapy-related fatigue and quality of life.
P2860
Q21136326-3CB8CD84-4B6A-4A78-BB64-2CCCE51DD0C4Q21143876-E4058766-AAE2-413C-AA7D-7AD5E31DFD91Q24186942-B2A35281-4340-4A55-944A-914765B1C5EAQ24200502-0FF7348F-2D95-43AE-A498-55C14C716214Q24201652-641C57A1-0572-4F3A-AEAE-B82045737455Q24202470-F87AA32A-3BA6-4B73-8BD1-F4C0D1371FC2Q24243060-8C422A27-5AE4-4765-B236-D800A006976FQ24243212-172DF051-D8BB-4472-8041-1F37422C6C45Q24244256-48D55E64-050C-40D2-9463-AD7F8BF04F0CQ24244881-66BD661F-A6BF-409C-BE89-EE270144AB26Q24531307-7828FA0B-ED48-4294-9C5C-F99C8C22558CQ24540524-4131C5F8-A8E4-45F2-A3F3-7A8856D0C7DFQ24644317-8553638B-DC08-4EF2-BDA7-13A0C7495EEFQ24644493-2247D8C0-AD0A-4790-A9B8-90B9FFD8C96DQ24648673-DC8BE115-4CF6-47BF-9317-7B3814E483A3Q24654791-4ED35801-8095-4A56-A3C2-C5996210DE80Q24678072-88E036A5-05E5-4108-9CBC-C37A7A757D96Q24792822-0403C37C-517A-4F82-A3A8-A4F8D2B6E0AFQ24816427-71C1B133-D819-4BE9-B8E3-C01212D56697Q24816443-89AC359D-6987-4F1C-9E58-49063FD39E74Q26471829-3D01432C-F8F5-4AF0-AD73-7166EA80A3FCQ26800853-2E75EA4F-918C-4BA2-A273-506DCEF2270EQ26822640-98F92C11-4F85-4CFD-ADA1-E617EB4D5C9BQ26992736-34E12F18-46D1-4042-A22A-934B097A3D37Q27021421-112E5C46-6398-44D3-964C-73359F9BE1FAQ27021794-BC76659D-B272-4C0E-83E3-C0C42070DCD5Q28391237-2425C76E-C082-4B29-A6D2-F6B7DDF1C68FQ28533798-12352D1B-C312-47AD-9F42-2780BF4551AAQ28596757-E3707132-3442-455F-BFC5-7ABB41D5584AQ30362026-06E02F50-0F02-462C-8C83-BCCDF5246187Q30492805-30A4C2EF-E54A-46F3-8681-52A13D2ED405Q33373384-C8DFF4C7-E0E5-45A0-A826-43884E773007Q33564426-E743452A-686A-4833-BEEC-6FAF6E15BE48Q33761086-D37079C3-1AD1-449B-B0B4-0B9F448E5726Q33792060-117CB46F-0EB0-488C-B278-5FBDDDA2F7F3Q34030321-69423F17-1BB6-4B64-A851-D6EF95C844A8Q34040520-1E119400-33DC-48B0-A827-F1AF299D1117Q34137350-EE0BEE16-96D9-4994-93F6-C850F6A00DF8Q34140158-4B16A993-90C6-4CD5-B539-A5331C4550A4Q34349450-7C8F9B7A-4D5F-47E9-A8E0-0C07B612A458
P2860
Vitamin C pharmacokinetics: implications for oral and intravenous use.
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Vitamin C pharmacokinetics: implications for oral and intravenous use.
@ast
Vitamin C pharmacokinetics: implications for oral and intravenous use.
@en
type
label
Vitamin C pharmacokinetics: implications for oral and intravenous use.
@ast
Vitamin C pharmacokinetics: implications for oral and intravenous use.
@en
prefLabel
Vitamin C pharmacokinetics: implications for oral and intravenous use.
@ast
Vitamin C pharmacokinetics: implications for oral and intravenous use.
@en
P2093
P1476
Vitamin C pharmacokinetics: implications for oral and intravenous use.
@en
P2093
Hugh D Riordan
Mark Levine
Robert A Wesley
Sebastian J Padayatty
Yaohui Wang
P304
P356
10.7326/0003-4819-140-7-200404060-00010
P407
P577
2004-04-01T00:00:00Z